Inventor · disambiguated record
Paul Stuart Hinchliffe
Also filed as: HINCHLIFFE PAUL · HINCHLIFFE PAUL STUART
4 granted patents·7 pending applications·8 citations·filing 2012–2025
65Inventor score
Files withGW RES LTD3KALVISTA PHARMACEUTICALS LTD3BLACKABY WESLEY PETER2ASTRAZENECA AB1COMPASS PATHFINDER LTD1
Top patents by PatentIndex Score
11 records- 0189US11248001B2PCSK9 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Feb 15, 2022·6 cites·6 claims
- 0259US9127007B2FSH receptor antagonistsBLACKABY WESLEY PETER·Filed 2012·Granted Sep 8, 2015·1 cites·10 claims
- 0359US9044463B2FSH receptor antagonistsBLACKABY WESLEY PETER·Filed 2012·Granted Jun 2, 2015·1 cites·12 claims
- 0454US10155259B2FSH receptor antagonistsMERCK SHARP & DOHME·Filed 2015·Granted Dec 18, 2018·0 cites·12 claims
- 0554US2024238218A1Resorcinol derivative as a pharmaceutically active compound and method of preparation thereofGW RES LTD·Filed 2022·Application pending·0 cites
- 0652US2024254066A1Rescorcinols, methods for their manufacture, and uses thereofGW RES LTD·Filed 2022·Application pending·0 cites
- 0750US2024025858A1Cannabinoid derivatives as pharmaceutically active compounds and method of preparation thereofGW RES LTD·Filed 2021·Application pending·0 cites
- 0849US2025352514A1Salt forms of bis(3-(2-(dimethylamino)ethyl)-1 h-indol-4-yl) 3,3'¬oxydipropionateCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 0948US2022289727A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1043US2022298138A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
- 1143US2022298141A1Enzyme inhibitorsKALVISTA PHARMACEUTICALS LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Stuart Hinchliffe files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →